Table 2.
Incidence rate ratio of PJP in individual autoimmune rheumatic diseases
| N | PJP event | PY | IR | IRR | 95% CI | |
|---|---|---|---|---|---|---|
| Comparison | 412468 | 61 | 2583087 | 0.24 | Reference | |
| RA | 50341 | 56 | 383168.8 | 1.46 | 6.19 | (4.31–8.89) |
| SLE | 23716 | 74 | 195431.7 | 3.79 | 16.03 | (11.42–22.50) |
| SjS | 23048 | 20 | 126784.1 | 1.58 | 6.68 | (4.03–11.07) |
| PM/DM | 2589 | 21 | 16840.42 | 12.47 | 52.81 | (32.16–86.70) |
| SSc | 2499 | 7 | 17084.68 | 4.10 | 17.35 | (7.94–37.93) |
| SV | 924 | 3 | 6162.76 | 4.87 | 20.61 | (6.46–65.70) |
ARD, autoimmune rheumatic diseases; PJP, Pneumocystis jirovecii pneumonia; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SjS, primary Sjogren’s syndrome; PM/DM, polymyositis/dermatomyositis; SSc, systemic sclerosis; SV, systemic vasculitis; PY, patient year; IR, incidence rate of 100,000 patient year; IRR, incidence rate ratio; CI, confidence interval